STOCKS MIXED AS FOCUS TURNS TO U.S. INFLATION DATA

UBS boosts S&P 500 year-end target to 5,600 on 'robust' earnings growth

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

1.5000

-0.1400

(-8.54%)

At close: 04:00PM EDT

1.4600

-0.04

(-2.67%)

After hours:

04:02PM EDT

Trade prices are not sourced from all markets

Press Releases

PR Newswire
Nektar Therapeutics Reports First Quarter 2024 Financial Results
Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024.
PR Newswire
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.
PR Newswire
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at the upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 28, 2024 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time.